.: "arise: a phase 3 randomized trial of erenumab for episodic migraine."
.
it's the first successful medical treatment of a human fetus for the underlying cause of a genetic disorder, experts say
.of the life claims declined, 0.85 per cent were due to mis-representation and 0.16 per cent due to the definition of terminal illness not being met.
.